| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Arterial Occlusive Diseases | |||||
| Cardiovascular Diseases | |||||
| Heart Diseases | |||||
| Vascular Diseases | |||||
| Diabetes Mellitus | |||||
| 2 | More general conditions related to this trial | ||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Metabolic Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| niacin | |||||
| pravastatin | |||||
| beta-carotene | |||||
| vitamin E | |||||
| dietary supplements | |||||
| vitamin C | |||||
| warfarin | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Beta Carotene | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anticholesteremic Agents | |||||
| Antilipemic Agents | |||||
| Antimetabolites | |||||
| Enzyme Inhibitors | |||||
| Growth Substances | |||||
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | |||||
| Micronutrients | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| Vitamins | |||||
| 6 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||
|
